The role of interleukin-2, all-trans retinoic acid, and natural killer cells: surveillance mechanisms in anti-GD2 antibody therapy in neuroblastoma
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The role of interleukin-2, all-trans retinoic acid, and natural killer cells: surveillance mechanisms in anti-GD2 antibody therapy in neuroblastoma
Authors
Keywords
Anti-GD2 antibody, IL-2, Neuroblastoma, NK cells, Missing-self
Journal
CANCER IMMUNOLOGY IMMUNOTHERAPY
Volume 67, Issue 4, Pages 615-626
Publisher
Springer Nature
Online
2018-01-11
DOI
10.1007/s00262-017-2108-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Development and characterization of a human orthotopic neuroblastoma xenograft
- (2015) Elizabeth Stewart et al. DEVELOPMENTAL BIOLOGY
- Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
- (2015) James Larkin et al. NEW ENGLAND JOURNAL OF MEDICINE
- HTSeq--a Python framework to work with high-throughput sequencing data
- (2014) S. Anders et al. BIOINFORMATICS
- Phase I Trial of a Novel Anti-GD2 Monoclonal Antibody, Hu14.18K322A, Designed to Decrease Toxicity in Children With Refractory or Recurrent Neuroblastoma
- (2014) Fariba Navid et al. JOURNAL OF CLINICAL ONCOLOGY
- CD19-Targeted T Cells Rapidly Induce Molecular Remissions in Adults with Chemotherapy-Refractory Acute Lymphoblastic Leukemia
- (2013) R. J. Brentjens et al. Science Translational Medicine
- Long-term continuous infusion of anti-GD2 antibody CH14.18/CHO in relapsed/refractory neuroblastoma patients
- (2013) Holger Lode et al. Journal for ImmunoTherapy of Cancer
- Enhancement of the anti-melanoma response of Hu14.18K322A by αCD40 + CpG
- (2012) Kory L. Alderson et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- The Pediatric Cancer Genome Project
- (2012) James R Downing et al. NATURE GENETICS
- Genotypes of NK Cell KIR Receptors, Their Ligands, and Fc Receptors in the Response of Neuroblastoma Patients to Hu14.18-IL2 Immunotherapy
- (2010) D. C. Delgado et al. CANCER RESEARCH
- GD2 expression is closely associated with neuronal differentiation of human umbilical cord blood-derived mesenchymal stem cells
- (2010) Hye Jin Jin et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma
- (2010) Alice L. Yu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Anti-GD2 with an FC point mutation reduces complement fixation and decreases antibody-induced allodynia
- (2010) Linda S. Sorkin et al. PAIN
- KIR and HLA Genotypes Are Associated with Disease Progression and Survival following Autologous Hematopoietic Stem Cell Transplantation for High-Risk Neuroblastoma
- (2009) J. M. Venstrom et al. CLINICAL CANCER RESEARCH
- NK Cell Responsiveness Is Tuned Commensurate with the Number of Inhibitory Receptors for Self-MHC Class I: The Rheostat Model
- (2009) N. T. Joncker et al. JOURNAL OF IMMUNOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now